Need an advice?

Just diagnosed with a prostate cancer?

  • If you have been recently diagnosed with a prostate cancer or you have been suffering from it for some time, you may be scared, worried or even angry for the situation.
We know that diagnosis ‘prostate cancer’:
  • makes you feel as if life has come to an end and there’s a little time left;
  • national health system often stirs up negative emotions — stress and feeling that you have to live by the system’s rules and ‘lucky’ hand of a doctor;
  • unpredictability of real costs entailed by the disease, related to additional diagnostics, waiting for your turn, lack of understanding of doctor’s fee, hard to predict costs of post-operative and rehabilitation period, which are usually not covered from the state budget, give rise to the same amount of stress and painfully hits your budged.
You might be afraid of:
  • recurrence after previous treatment;
  • serious post-operative consequences and possible rehabilitation
  • losing your masculinity (potency).
Several our customers have told us:
  • I don’t want to wear nappies for the rest of my life;
  • I don’t want to be a useless husband to my wife.
We are here to support you and to help you deal with this problem. Here you can find out more what to do to help yourself.

If you wish:

  • To recover completely (by destroying the detected tumour without consequences and side effects);
  • To get an instant solution, rather than wait for the tumour to progress and spread outside the prostate, create metastases and result in a lethal outcome;
  • Be treated with a method allowing to keep previous quality of life, potency and dignity of a man;
  • To get back a peace of mind and sleep in the night knowing that the problem (cancer) has been solved;
  • To continue living just like before, i.e. if you are not willing to change the existing lifestyle due to an illness, which is unavoidable in case of conventional treatment (prostatectomy);
  • To avoid potency disorders;
  • To avoid urinary incontinence or similar disorders;
  • Not to worry whether PSA level has increased once more every three months, if you are assigned for an active surveillance of the tumour.

How can we help in case of a prostate cancer?

  • Our team has highly qualified doctors (urologist, radiologist, radiation oncologist, medical oncologist) who have devoted their professional life to prostate cancer treatment;
  • Each individual case is assessed by the specialist team — within the framework of the board of specialised doctors;
  • Our customers have both conventional and more advanced methods to diagnose prostate cancer, such as targeted biopsy, 3T MRI and PET-CT;
  • Our specialists perfectly know all conventional treatment methods for prostate cancer and have gathered more than twenty years of experience in using them in treatment;
  • Specialists from the SRC SIGULDA have mastered the latest medical technologies and prostate cancer treatment methods that help to recover completely;
  • our specialists work according to the guidelines of professional association of doctors on the basis of the latest clinic studies and experience of the leading European clinics, in line with especially elaborated prostate cancer treatment protocol, and they also teach other professionals working in this field about innovations in prostate cancer treatment.

Apply for a free of charge consultation on-line:

Our customer consultants will contact you as soon as possible. If you wrote us during a holiday or after the working hours, we will definitely answer you the next day.
You can also call us +371 20270077

We undertake to protect your personal data and keep them confidential according to the law. You can read our Personal Data Processing Policy here.

How to know if I have a prostate cancer?

PSA (prostate-specific antigen) is a substance produced by the prostate. PSA mainly concentrates in sperm, and some amount is found also in blood. Majority of healthy men has low PSA level in blood — 4 ng/ml (nanograms per millilitre). An elevated PSA level in blood increases the likelihood of having prostate cancer. If the PSA level in blood stays between 4 ng/ml and 10 ng ml, a possibility to detect prostate cancer is 25%, if the PSA level exceeds 10 ng/ml, the likelihood of having the prostate cancer steps up to 50%. In some cases the prostate cancer can be detected also if the PSA level in blood is below 4 ng/ml.

Factors elevating PSA level in blood (except for the cancer).

read more…

• BPH (benign prostatic hyperplasia): prostate enlargement that is not related to cancer and that develops in many elderly men.
• Age: the PSA level slowly increases with the age even if no changes occur in the prostate.
• Prostatitis: prostate infection or inflammation.
• Ejaculation may increase the PSA level for a while, however it will reduce afterwards.

Finding out your PSA level is important not only for an early diagnostic of the prostate cancer. It can be useful also in other cases.

• For men already diagnosed with the prostate cancer, the PSA level together with other analyses can help to decide what additional examinations to take and what therapy method to choose.
• Very high PSA level may indicate that the tumour has spread outside the prostate. It also helps choosing the treatment method, because some of them cannot be applied if cancer cells have spread to lymph nodes or other organs.
• The PSA level helps finding out the efficiency of treatment and whether there is cancer recurrence after the treatment.
• If you have chosen ‘surveillance tactics’ instead of immediate treatment, you can follow-up cancer development with PSA level tests and start treatment, if necessary.

If the prostate cancer continues growing after the treatment (recurrence) or it has spread outside the prostate (metastases), the PSA level cannot capture these changes. The PSA level cannot be used to predict what symptoms are about to develop and to predict the survival. Many patients have very high PSA levels however, they feel good and have no complaints. Others, in turn, have low PSA levels and have typical complaints. Also, if a person has comorbidity, it is always useful to follow-up changes in the PSA level rather than evaluate its level from one blood count.


In this examination the doctor puts on medical gloves, spreads some lubricant on his finger and guides it into the rectum. The prostate is located next to the rectum and majority of cancers that originate in the prostate forms in the part that is adjacent to the rectum, therefore it can be palpated well. An increased prostate size that can be detected or uneven or hardened parts can be palpated indicating at probable cancer during the examination. Even though the examination is unpleasant, it is not painful and does not request much time.

read more…

Digital rectal examination is not as efficient as detecting of PSA level, nevertheless, sometimes cancer can be detected in men with normal PSA level in blood. Digital rectal examination must be performed also if the prostate cancer has been detected. This examination can reveal how wide the cancer has spread. It can also show whether the cancer has returned after the treatment.


Transrectal ultrasonography uses ultrasound waves to create prostate image in a computer. In order to perform this examination a small probe is inserted in the rectum. This probe sends sound waves that, when arriving at the prostate, generate an ‘echo’ also received by the probe. The computer translates the echo into a black and white image.

read more…

The examination takes several minutes. You will feel a slight pressure when the ultrasound probe is inserted into the rectum, however, usually it is not painful. Transrectal ultrasonography is applied also during the biopsy to make sure that biopsy needle is inserted correctly, and a sample is taken right from the area of the affected prostate.


If some complaints or results of analyses raise a suspicion that you might have a prostate cancer, you should perform prostate biopsy to confirm the diagnosis completely.

The biopsy is the only way to find out precisely whether you have the prostate cancer.

read more…

Cells are sampled from the prostate during the biopsy and then sent to a laboratory where they are tested for cancer cells.
Most frequently the biopsy is performed with a hollow needle. The procedure goes like this: during the transrectal ultrasonography, following an image on the computer, the doctor inserts the needle in the prostate through the rectum wall. When the needle is removed, it has a small piece of tissue (approximately 1 cm in length and 2 mm in width) inside. Some doctors prick the needle through the skin between the anus and testicles.

Even though such description brings an association of a painful procedure, it causes only minor discomfort, because everything happens very fast. The doctor may apply local anaesthesia for the period of examination. The biopsy lasts for approximately 15 minutes. You can ask the doctor for local anaesthesia before the procedure. Sometimes tissue samples are taken from different parts of the prostate. Ask your doctor how many samples are to be taken.

In order to decrease a risk of infection, it is recommended to empty the rectum before the procedure, for example with Microlax. The doctor may also prescribe a short course of antibiotics before and after the biopsy. Several days after the procedure you might feel mild pain in the area of biopsy, some blood in the urine or mild bleeding from the rectum can also occur. Some men can have blood admixture in the sperm for one or even two months after the biopsy.

The cancer can be located only in a small part of the prostate rather than to overtake it completely Therefore, in some cases the biopsy sample might not show any cancer cells although the cancer is there. It is called a ‘false negative response’. If your biopsy sample does not contain cancer cells, however, the doctor is sure that you have cancer, the biopsy must be repeated. In order to avoid another false negative response, a magnetic resonance imaging of the pelvis is advisable before the biopsy. Thus, it is possible to target the needle more precisely in the suspicious part of the prostate. This method is called ‘targeted biopsy’.

Biopsy sample is sent to a lab. Doctor is checking the sample for cancer cells. If the cancer cells are found, the stage of the cancer must be detected. Grouping of cancer cells into stages allows to determine the growth and expansion rate of the tumour more precisely.

Biopsy conclusion shows the cancer stage (if applicable). Biopsy conclusion may contain also other information that helps evaluating the tumour. It may be:

• number of biopsy samples containing cancer cells (for example seven out of 12 samples contain cancer cells);
• number of cancer cells in each sample (in percentage);
• whether the cancer is located in one section of the prostate (right or left) or both (bilateral).

Sometimes the cells do not look like cancer cells, however they are not normal cells either. In such case a repeated biopsy is recommended.

Shortcomings of the method

According to different data sources, up to eighty percent of men, who had prostate biopsy performed, are not diagnosed with the prostate cancer or the tumour found is not aggressive. Therefore, many men are repeatedly subject to unnecessary medical manipulation, which does not lead to completely accurate and safe detecting of the prostate cancer and its aggressiveness level. Blood is often found in urine and sperm after the manipulation, the risk of infection and bacterial infection increases and some also report disturbed potency after repeated prostate cancer biopsies.
You can take 4Kscore® Test to find out if you need to have a prostate biopsy.


4Kscore® Test helps urologist to identify aggressiveness level of the prostate cancer before biopsy and allows finding out a likelihood of detecting an aggressive and high-risk prostate cancer.

What is 4Kscore® Test?

4Kscore® Test relies on the measurement of four prostate-specific kallikreins in the blood: total PSA (prostate-specific antigen), Free PSA, Intact PSA, and Human Kallikrein 2 (hK2).

read more…

The blood test results are combined with the clinical information (patient age, health condition, medical record, heritability risk – information about whether any close relative such as grandfather, father, brother or uncle had prostate cancer, as well as history of previous PSA measurements) in an algorithm helping to calculate the personal score of cancer aggressiveness risk for each patient

What are advantages of 4Kscore® Test?

4Kscore® Test can help decreasing the number of biopsies performed. If the risk of prostate cancer detected in the test is low, the patient and urologist can decide together not to do prostate biopsy and avoid unpleasant sensations and complications, such as bleeding and infection that might occur from the biopsy procedure.

If a low prostate cancer risk (Gleason score 6) is detected in the test, the patient may also avoid aggressive treatment of the prostate cancer. 4Kscore® Test can also provide information about risk of metastases in future in patients with low PSA levels.

Efficiency of the test is based on over a decade of research conducted in Europe, the United States of America by comparing several thousands of patients who had prostate cancer biopsy. Results of the biopsies performed are compared to results of 4Kscore® Test. The test is very accurate, and it has become very popular, because it is both comfortable for a patient and provides additional information for the treating doctor to make the best decisions.

More information about 4Kscore® Test is available at


Magnetic resonance imaging of pelvis is used to determine spread of the tumour in prostate and pelvic lymph nodes. The latest generation magnetic resonance imaging allows detecting tumour size and location in the prostate rather accurately, therefore, it is worth doing the magnetic resonance imaging before prostate biopsy.

read more…

Magnetic resonance imaging is not harmful to health, it is a high-resolution diagnostics with high preciseness for all parts of the body, used also in diagnostics of the prostate cancer.

The examination usually lasts for 15-30 minutes. A contrast agent might be administered, if needed, as it improves diagnostic accuracy. Medical radiologist decides whether a contrast agent needs to be used, basing on the clinical problem, renal function of the patient and, if needed, other parameters of the blood count. Contrast agent is administered intravenously.

During the examination a patient must be placed in a tunnel with a magnetic field, therefore, claustrophobic (being afraid from narrow spaces) patients must inform the doctor or magnetic resonance imaging technicians about his or her feelings. Medical radiologist assesses each case and decides on further examinations.

Before magnetic resonance imaging the patient needs to inform the referring doctor as well as magnetic resonance imaging technicians if he/she has:

  • cardiostimulator;
  • neurostimulator;
  • hearing implants;
  • artificial ventricles, aneurysm clips, other metallic implants;
  • metal foreign bodies (bullets, chips, metal staples, as well as metal prosthetics in a hip joint and other body parts.


Computed tomography for pelvis minor and bones can detect spread of tumour metastases in the bones and pelvis minor. Computed tomography (CT) is a radiology examination method combining x-rays and computer technologies. Images of patient’s body are generated from beams of x-rays shot from various directions. Information is digitally transformed giving 2D and also 3D images, that clearly present patient’s tissues and organs.

The examination is painless. If needed, a contrast agent can be administered intravenously.

Computed tomography has its drawbacks when it comes to examining of the cancer. It cannot detect tumour foci smaller than 5-10 mm in diameter, and it can also give false positive findings.

Bone scan is used to detect whether the cancer has spread in the bones.

A radioactive substance with short half-life is administered into the vein and it is rapidly discharged from the body. Radiation dose that you receive during an examination is not larger than radiation during an x-ray scan.

read more…

Scintigraphy does not always show cancer metastases in bones. Today positron emission tomography is used to detect bone metastases.


PET-CT technology is one of the most advanced and most precise cancer diagnostic methods in the world, which performs two examinations in one equipment — positron emission tomography (PET) and computed tomography (CT). A PET-CT scan combines images from both examinations, generating very high-quality hybrid image, specifically showing prostate cancer cells and providing very accurate information about malignant changes in the body.

read more…

If a man is diagnosed with the prostate cancer, a PET-CT scan is the most efficient and accurate method for detecting the spread of cancer and discovering possible metastases. Most recent studies show that PET-CT has a number of other advantages in comparison to other conventional methods used so far to diagnose prostate cancer — ultrasonics, computed tomography, magnetic resonance imaging and bone scan.

Advantages of PET-CT scan
• If a recurrence of tumour is suspected after previous conventional surgery or radiotherapy, only PET-CT scan will identify the malignant cells while PSA level is less than 1.0 ng/ml;
• Studies show that PET-CT allows detecting metastases less than 5 mm in the lymph nodes;
• PET-CT method is suitable also for men who suspect a prostate cancer and their PSA level is elevated, however biopsy has not confirmed it.
• In case of individual metastases PET-CT scan is combined with robotic radiosurgery;
• In case of wide-spread metastases PET-CT method can be combined with radionuclides Y-90 or Lu-177-PSMA.
• PET-CT method not only helps to diagnose tumour accurately, but also to plan further therapy in all details — to determine whether a patient needs radiation or chemotherapy treatment course or a hormone therapy.

How does the examination proceed?
Equipment of PET-CT examination visually resembles a computed tomography device, the only difference being two gantries (rings) — the first performs computed tomography scan and the second performs positron emission tomography. Two gantry design of the equipment reduces discomfort and claustrophobic sensations in patients during the exam. During the examination the patient must lie down on the examination table while being slowly moved through the diagnostic device. Hands must be kept behind the head and patient should lie still during the examination. In addition to the PET-CT scan a doctor sometimes refer the patient to computed tomography with a contrast agent, which allows obtaining more information for diagnostics and in many cases it can be decisive for more clarity.


What are treatment possibilities?

Treatment of the prostate cancer depends on the stage of a tumour.

If you have a prostate cancer, several aspects must be considered before choosing the treatment method, namely — your age, general health condition, treatment goal and your attitude towards side effects. For example, many men cannot imagine their life with urinary incontinence or potency disorders. Others, however, want to remove cancer cells fully rather than focus on possible side effects. Nevertheless, each situation is unique, and many factors come in play, so primarily every patient must visit professional and experienced specialists, so that the most efficient treatment option is chosen when examining each particular case.

Is applied in cases of low risk prostate cancer, where a risk of spreading and progressing of the tumour is very low. The patient tests PSA level in blood on a regular basis and visits an urologist (once in 3-6 months). Steep PSA increase calls for a radical treatment.

Surgical treatment is intended for tumours in stage I, II and sometimes III. A surgery usually is an option for patients if the predictable survival exceeds 10 years. Entire prostate with the seminal vesicles are removed completely during the surgery. In case of high risk tumour the nearby lymph nodes are also removed together with the prostate. Post-operative complications may involve urinary incontinence and erectile dysfunction.

read more…

Oncologic results of surgical treatment are generally similar for all methods. The quality of a surgery depends on surgery experience and knowledge of the urologist.
If the prostate cancer grows outside its borders or has created metastases, i.e. if tumour foci have been detected in lymph nodes or other soft tissue and/or bones, it is called stage III-IV tumour. In this stage a surgery has no decisive impact, because the tumour cannot be removed completely, and any invasive manipulation exhausts the body even more.

When treating tumours in stage III and IV, most commonly used method is radiotherapy, robotic radiotherapy, hormonal therapy or a combination of such methods.


Radiotherapy is a treatment using intense energy beams (such as x-ray beams) to kill or devastate cancer cells. The beams come from a source located outside the body (external beam radiation) or from radioactive materials placed directly in the tumour (internal radiation or brachytherapy).
Radiotherapy is sometimes chosen as the first treatment method for a low risk prostate cancer that has not spread outside the prostate or has affected only nearby tissue.

read more…

Sometimes it is applied if a surgery cannot remove all cancerous tissue or there is a recurrence after a previous radical treatment of the prostate cancer in form of a surgery. In case of a primary tumour a chance to be treated with radiotherapy is equal to that of a surgical treatment. If the cancer is found in last stages, radiotherapy can help to reduce the volume of the cancer and alleviate pain.

External beam radiation therapy means treatment of the prostate from outside with radioactive beams. Conventional radiotherapy is an alternative to the surgery. This method can be recommended for elderly patients or patients who do not want to undergo a surgery.
Each radiation session lasts for few minutes. Usually the course of treatment is seven to nine weeks and it progresses on an out-patient basis, five sessions per week. Treatment as such is fast and painless. Each radiation session lasts for few minutes.

Today, the conventional radiotherapy is chosen much more seldom than before. The latest radiotherapy technologies allow a doctor to treat the very prostate itself with more success and without affecting the surrounding tissue. These methods are intended for more efficiency and less side effects.

Radiotherapy also has its complications, which can be brought to a minimum as the technologies develop. However, inflammation of the bladder manifesting as frequent and painful urination is possible after a treatment with older generation equipment. If the large intestine is affected, it can lead to painful diarrhea, even with an amount of blood. This inconvenience, however, is transitional and do not develop in all patients.


Robotic radiosurgery with CyberKnife or hypofractionated radiation therapy is a type of external beam radiation therapy that is currently recognised as the most efficient, safest low or medium risk prostate cancer treatment method with the least impact on the quality of life. It is applied to treat prostate cancers in stage I and II. Treatment as such is fast and painless. Each radiation session lasts for 45-60 minutes. Usually the treatment course consists of five sessions during one week on an out-patient basis.

read more…

This method is recommended to patients not eligible for a surgical treatment or in cases where the side effects of a surgical treatment can have a significant impact on the quality of life of a man. 10 years of studies of this method show a similar efficiency in controlling the tumour’s recurrence to that of a surgical treatment and a better efficiency in comparison to the external beam radiation.
Hypofractionated radiation therapy also can lead to complications, however, in comparison to the surgery or conventional radiotherapy, they are reduced to a minimum. In some cases an urethra irritation is possible, manifesting as more frequent and less pleasant urination and, possibly, mild diarrhea. This inconvenience usually disappears within one month after the treatment.

Robotic radiosurgery with CyberKnife can be also applied for tumours in stage III and IV.
If the prostate cancer has been detected where it has already grown outside the prostate capsule, the robotic radiosurgery can be complemented both with conventional treatment methods and surgical treatment and external beam radiation therapy. In case of treatment of a previously treated cancer, and if a recurrence or separate metastases in bones, soft tissue or in other parts are established, robotic radiosurgery ensures high control of local recurrence and allows postponing the hormone replacement therapy and extend survival without symptoms.


Internal radiation of the prostate or brachytherapy means placing radioactive sources (metallic radioactive seeds) inside the prostate where they do their work for an extensive period of time. This method has less distinct side effects if compared to the external beam radiation therapy, because they have less influence on nearby organs. This method is newer and more efficient for tumours in stage I and II. This method requires anaesthesia. This method is not currently available in Latvia.

Goal of the hormonal therapy is to reduce the level of male sex hormones (androgens), including testosterone, in blood. Androgens that usually form in the testes stimulate an increased growth of prostate cancer cells. If the level of androgens is reduced, the prostate cancer either shrinks or it grows considerably slower. Hormonal therapy can control cancer, but it cannot treat it. If the hormonal therapy is continued for 3-4 years, so-called hormone-refractory state can occur, i.e. tumour cells become resistant against hormones.

Chemotherapy means administration of medications that kill cancer cells. These medications are most commonly administered through vein. Some medications can be in form of pills. When they reach the bloodstream, they spread around the body and kill cancer cells.
In case of a prostate cancer chemotherapy is chosen where the cancer cells have spread in entire body and hormonal therapy is inefficient. This is not a standard therapy in early stages of the prostate cancer. Studies are taking place to prove efficiency of a short-term chemotherapy course of treatment after surgical removal of the prostate.

read more…

Just like hormone therapy, the chemotherapy does not treat the cancer entirely. It cannot destroy all cancer cells, however it can slower the growth of the cancer and reduce symptoms, thus leading to a better quality of life.


Why do we recommend treating primary prostate cancer with robotic radiosurgery with CyberKnife?

    • Robotic radiosurgery with CyberKnife is recognised to be the most efficient and safest treatment method of a primary prostate cancer of low or average risk with the least impact on the quality of life of patients suffering from stage I and II prostate cancer[1];
    • Expected therapeutic results are based on quantitative and qualitative clinical research;
    • Efficiency is proven in patient surveillance for more than 10 years;

read more…

    • Prostate cancer is destroyed without pain, without a need for post-treatment rehabilitation, at a precision of a millimetre, ultimate prevention of a human mistake and minimum risk of side effects;
    • Until 2018, more than 20,000 prostate cancer patients worldwide have been treated with CyberKnife;
    • The method makes patients feel better, because it destroys the tumour in a comfortable and efficient way, not affecting the quality of life;
    • Prevents disease recurrence in up to 98% of cases;
    • Keeps male functions (potency) working and supports dignity of a man;
    • Allows avoiding consequences and side effects of conventional therapy;
    • Improves sleep during nights, helps to reclaim peace of mind knowing that prostate cancer has been treated.


prostate cancer

5 days instead of 30 days

Diagnosis: Low risk prostate cancer.

Oscar, 75 years (patient’s name has been changed):

I am 75 years old and I have always thought of myself as a healthy person. I have been living healthy since young age, and I still continue working. The only exception in my health condition is that i have to get up for several times during the night to go to toilet. Sometimes it causes inconvenience, but apart from that, other functions seem to be alright. Besides, a year ago I scheduled a visit to urologist.

During the examination the treating doctor detected enlarged prostate and that the level of prostate-specific antigen (PSA) has increased from 5 to 11.

Read more

prostate cancer treatment results

I could not have received such treatment in Great Britain

Diagnosis: prostate cancer, ogliometastases in lymph nodes, bones, ribs.

Peter from Great Britain, 70 years (patient’s name has been changed):
We are more than happy with the treatment we have received from you. Your diligence, speed of response to medical questions and clear communication is the reason we chose to come to Latvia in the first place, rather than Eastern Europe, when we could not afford treatment in the UK.

You have been excellent in always responding quickly and efficiently to any situation and we realised just how dedicated you are to your job, when we came for treatment in February. You should be very proud of the work you do and you are a credit to the Sigulda CyberKnife centre.

Read more

What do we offer?

  • An opportunity and time to continue your daily works and to live a good quality life, as if you never had a cancer;
  • The same treatment technology and quality of results as in the best European clinics;
  • 2x lower costs than in Germany, Great Britain or anywhere in the European Union;
  • Save time, spent on post-operative care and rehabilitation;
  • Receive attention of our specialists before and after the therapy;
  • Availability of on-line and on-site consultations, a possibility to call a doctor and get instant response or solution to your problem;
  • Professionalism, understanding and considerateness;
  • Understandable, predictable costs, without hidden additional costs.

Why choosing examinations and treatment in Latvia?

Latvian clinics are ready to admit foreign patients and provide high quality services and individual approach to each situation.

Advantages of private medicine in Latvia:

  • High quality of the product and service;
  • Professional staff;
  • Availability of latest technologies used in the services;
  • No queues and
  • Competitive price.

read more…

The second most important factor is the unique healing resources of nature of Latvia, the mild seaside climate that facilitates treatment of different diseases, encourages recovery, rehabilitation as well as recreation and provision of wide range of beauty procedures. Besides, the clinics can offer English-speaking staff to avoid any language barrier: free communication about problematic issues makes the patient feel safe, encourages reliance and confidence in the right choice to receive the best value high quality services from professional staff in Latvia.

Thirdly, flight from London, Birmingham, Edinburgh or Dublin to Riga takes less than three hours. Besides, our clinics can arrange meeting the patients in the airport and transfer to the hospital. Five- and four-star hotels are 2-3 times cheaper than in Great Britain, and their costs can also be included in the bill for treatment services.


Prostate cancer treatment refunded by NHS

Cancer treatment abroad refunded by the NHS? Now it is possible! People who are diagnosed with prostate cancer and who are living in the United Kingdom have the right to receive private prostate cancer treatment refunded by NHS in the EEA (European Economic Area).

If you have been recently diagnosed by a NHS doctor with prostate cancer or you have been suffering from it for some time we can offer you National Health Service (NHS) refunded robotic radiosurgery with Cyberknife. You could be candidate for prostate cancer treatment with Cyberknife even in the situation when the NHS doctor has suggested radical actions, like surgery.

You can get NHS funded Cyberknife treatment.

read more…

The residents of UK may get planned treatment abroad, eventually jump NHS waiting lists for prostate cancer treatment.

We understand that it may be complicated to complete all the necessary formalities with no outside help. Over a period of years, cooperation between the private clinics in Europe and the Medrefund LTD has evolved into a fruitful and reliable relationship – patients who have cooperated with Medrefund LTD have at least partially regained the money paid for cancer treatment abroad.

Jump NHS waiting list for prostate cancer treatment.

No more need to wait in a NHS queue or check your position in the NHS waiting lists! You can jump the NHS waiting list to go abroad and Medrefund LTD will make sure that the NHS refunds your treatment – go abroad and jump the NHS waiting list.

More about Medrefund LTD here:


jana irsa

Jana Irsa
Customer consultant

Doctor’s assistant will answer you and help to understand, which specialist is needed in your case

Read more

kirils ivanovs

Kirils Ivanovs
Urologist, andrologist

Experienced urologist, specialised in prostate cancer diagnostics, as well as potency disorder diagnostics and treatment

Read more


Maris Mezeckis
Radiation oncologist

The most professional and skilled specialist in prostate cancer treatment with radiotherapy robotic system CyberKnife

Read more

linda jurginauska

Linda Jurginauska
Medical oncologist

Open and considerate, professional specialist will help you if the prostate cancer is already in late stages or has come back after previous therapy

Read more

We recommend visiting other websites for more information:

Here you will find one of the most extensive resources about diagnostics and conventional treatment methods of prostate cancer:

Read more about one of the most advanced methods for diagnosing the prostate cancer in Latvia — PET-CT:

Read more about robotic radiosurgery method with CyberKnife M6:

Information about prostate cancer treatment with CyberKnife in Latvia:

Information about Latvia as medical tourism destination:

Apply for free of charge on-line consultation:

Our customer consultants will contact you as soon as possible. If you wrote us during a holiday or after the working hours, we will definitely answer you the next day.
You can also call us +371 20270077

We undertake to protect your personal data and keep them confidential according to the law. You can read our Personal Data Processing Policy here.

prostatas vēzis web page developed by Radiosurgery Centre Sigulda in cooperation with LATVIAN HEALTH TOURISM CLUSTER.

13 Lakstigalas Street, Sigulda Hospital, Sigulda, Latvia.

Call us:+371 20270077